AltMountain

OT SynBio Fund I, LLC

Boston, MA · CIK 1868470
Status: no Form D since Feb 2022. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

OT SynBio Fund I, LLC is a private investment fund based in Boston, Massachusetts. According to its most recent Form D, filed Feb 4, 2022, it has sold $4,896,050 of interests to 39 investors since its first sale in Aug 2021. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Richard Thoms; LLC Assure Fund Management II; LLC OT Management.

Total raised
$4,896,050Cumulative sales reported on Form D
Investors
39
First sale
Aug 12, 2021
Minimum investment
$100,000
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Richard Thoms; LLC Assure Fund Management II; LLC OT Management
Latest Form D
Feb 4, 2022

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​​⁠

Raise history

$4,896,050Aug 17, 2021: $4,140,625 raisedAug 18, 2021: $4,141,050 raisedAug 24, 2021: $4,441,050 raisedFeb 4, 2022: $4,896,050 raisedAug 2021Feb 2022
FiledFilingTotal raisedInvestorsSource
Feb 4, 2022Form D/A (amendment)$4,896,05039SEC.gov ↗
Aug 24, 2021Form D/A (amendment)$4,441,05038SEC.gov ↗
Aug 18, 2021Form D/A (amendment)$4,141,05037SEC.gov ↗
Aug 17, 2021Form D$4,140,62536SEC.gov ↗

4 Form D filings in the SEC's electronic records (2008 onward), the earliest on Aug 17, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about OT SynBio Fund I, LLC

What is the minimum investment for OT SynBio Fund I, LLC?

According to its latest Form D, filed Feb 4, 2022, the minimum investment OT SynBio Fund I, LLC accepts from an outside investor is $100,000.

Who can invest in OT SynBio Fund I, LLC?

OT SynBio Fund I, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has OT SynBio Fund I, LLC raised?

OT SynBio Fund I, LLC reports $4,896,050 sold from 39 investors on its Form D filed Feb 4, 2022. This is cumulative sales since the offering began, not current assets or performance.

Where is OT SynBio Fund I, LLC based?

OT SynBio Fund I, LLC is based in Boston, Massachusetts.

When did OT SynBio Fund I, LLC launch?

OT SynBio Fund I, LLC reports its first sale in Aug 2021.

Size compared with every private investment fund

Raised more than 36% of the 538 private investment funds based in Massachusetts, and more than 31% of all 10,333 that report sales.

Other funds with the same team

More private investment funds in Boston

Similar-size private investment funds in Massachusetts

All private investment funds in Massachusetts